首页> 外文期刊>Biological trace element research >Effect of Tungstate Administration on the Lipid Peroxidation and Antioxidant Parameters in Salivary Glands of STZ-Induced Diabetic Rats
【24h】

Effect of Tungstate Administration on the Lipid Peroxidation and Antioxidant Parameters in Salivary Glands of STZ-Induced Diabetic Rats

机译:钨酸盐给药对STZ诱导糖尿病大鼠唾液腺脂质过氧化和抗氧化参数的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Sodium tungstate is an alternative to reduce hyperglycemia for the treatment of diabetes. In previous work, we showed that the administration of sodium tungstate increased the specific activity of salivary amylase in the parotid gland. Here, we investigated the effect of the administration of sodium tungstate on the lipid peroxidation and some antioxidant parameters in the subman-dibular (SM) and parotid (PA) salivary glands of streptozotocin (STZ)-induced diabetic rats. Thirty-two male Wistar rats were divided into four groups (n = 8, each): control (C), control treated with sodium tungstate (CT), diabetic (D), and diabetic treated with sodium tungstate (CT). Sodium tungstate (2 mg/ml) was administered to the STZ-induced diabetic rats for 15 days. Malondialdehyde (MDA), reduced (GSH) and oxidized (GSSG) glutathione, and blood glucose concentrations were quantified. In addition, superoxide dismutase (SOD) and catalase (CAT) activities were assessed. Results revealed that diabetes caused an increase in MDA concentration in both glands, a reduction in the SOD activity in SM, and an increase in catalase activity in PA glands. Administration of sodium tungstate reduced the blood glucose levels and normalized the SOD activity in the SM and MDA levels in both glands of the STZ-induced diabetic rats. Catalase activity was increased in PA glands of diabetic and tungstate-treated animals (p < 0.05). The GSH/GSSG ratio was increased in SM glands of tungstate-treated animals (p < 0.05). Overall, the reduction of hyperglycemia by sodium tungstate reduced lipid peroxidation and caused alterations in the antioxidant system in the salivary glands of STZ-induced diabetic rats.
机译:钨酸钠是治疗糖尿病降低高血糖的替代品。在之前的研究中,我们发现服用钨酸钠会增加腮腺唾液淀粉酶的比活性。在这里,我们研究了钨酸钠对链脲佐菌素(STZ)诱导的糖尿病大鼠下颌下(SM)和腮腺(PA)唾液腺脂质过氧化和一些抗氧化参数的影响。32只雄性Wistar大鼠分为四组(每组8只):对照组(C)、钨酸钠治疗组(CT)、糖尿病组(D)和钨酸钠治疗组(CT)。钨酸钠(2mg/ml)给STZ诱导的糖尿病大鼠服用15天。测定丙二醛(MDA)、还原型谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)以及血糖浓度。此外,还评估了超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性。结果显示,糖尿病导致两个腺体中MDA浓度增加,SM中SOD活性降低,PA腺体中过氧化氢酶活性增加。钨酸钠可降低STZ诱导的糖尿病大鼠的血糖水平,并使SM中的SOD活性和两个腺体中的MDA水平正常化。糖尿病和钨酸盐治疗动物的PA腺体中过氧化氢酶活性增加(p<0.05)。钨酸盐处理的动物SM腺体中GSH/GSSG比率增加(p<0.05)。总的来说,钨酸钠降低高血糖可减少STZ诱导的糖尿病大鼠唾液腺中的脂质过氧化,并引起抗氧化系统的改变。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号